COR Cencora, Inc.
$324.35▼ -0.31%
Healthcare
Other
After hours
$324.35▲ +0.00%
Oct 28, 4:39 PM ET
Volume 1.08M
Avg Volume (10D) 1.27M
Key Metrics & Fundamentals
Market Cap
$61.89B
P/E Ratio
24.1
Div Yield
0.74%
52W Range
244.82 - 377.54
% vs 50 MA
0.48%
% vs 200 MA
2.23%
RSI-14
47.3
MACD Histogram
-1.1300
Beta (1Y vs SPY)
-0.15
Free Cash Flow
$2.43B
Gross Rev
$84.75B
Gross Profit
$3.61B
EBITDA
$1.51B
COGS
$81.15B
Operating Exp
$2.40B
Operating Income
$1.21B
EBIT
$1.21B
Pretax Income
$996.39M
Net Income
$763.52M
EPS (Diluted)
3.94
Price & Volume History
Loading chart…
Recent News
Cencora (COR) Reports Next Week: Wall Street Expects Earnings Growth
Zacks · Oct 28, 2026 9:00 AM ET
Cencora to Acquire AON in $2.4B Deal to Expand Oncology Network
Zacks · Oct 28, 2026 8:37 AM ET
Amgen vs. Novo Nordisk: Which Healthcare Giant's Stock Is a Better Buy in 2026?
Motley Fool · Oct 27, 2026 11:10 AM ET
Amgen vs. Johnson & Johnson: Which Healthcare Giant Has the Better Stock to Buy?
Motley Fool · Oct 24, 2026 12:31 PM ET
Cencora's Q4 2026 Earnings: What to Expect
Barchart · Oct 23, 2026 9:28 PM ET
Is American Oncology Network (AONC) Fully Valued Following Cencora's $2.4b Buyout Deal?
Simply Wall St. · Oct 23, 2026 8:21 PM ET
Amgen vs. Eli Lilly: Does the GLP-1 Mania Make LLY Stock a Better Buy in 2026?
Motley Fool · Oct 22, 2026 6:15 PM ET
Baird Adjusts Price Target on Cencora to $375 From $373
MT Newswires · Oct 21, 2026 11:55 AM ET
Cencora to Acquire American Oncology Network
MT Newswires · Oct 21, 2026 7:54 AM ET
Cencora to Acquire American Oncology Network to Strengthen Support of Community Oncology
Business Wire · Oct 21, 2026 7:30 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See COR's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.